Potential usefulness of apolipoprotein A2 isoforms for screening and risk stratification of pancreatic cancer

被引：22
作者：
Honda, Kazufumi [1 ,2 ]
Srivastava, Sudhir [3 ]
机构：
[1] Natl Canc Ctr, Res Inst, Div Chemotherapy & Clin Res, Tokyo 1040045, Japan
[2] Japan Agcy Med Res & Dev AMED CREST, Tokyo 1000004, Japan
[3] NCI, Canc Prevent Div, Rockville, MD 20852 USA
来源：
BIOMARKERS IN MEDICINE | 2016年 / 10卷 / 11期
关键词：
apolipoprotein A2 isoforms; early detection for pancreatic cancer; National Cancer Institute Early Detection Research Network; NCI EDRN; plasma/serum biomarker; COHORT-CONSORTIUM PANSCAN; MONOCLONAL-ANTIBODY; POOLED-ANALYSIS; ADENOCARCINOMA; SERUM; BIOMARKER; DIAGNOSIS; PLASMA; GLYPICAN-1; POPULATION;
D O I：
10.2217/bmm-2016-0209
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
Given the low incidence of pancreatic cancer in the general population, screening of pancreatic cancer in the general population using invasive modalities is not feasible. Combination of invasive screening with noninvasive biomarkers for pancreatic cancer and its precancerous lesions has the potential to reduce mortality due to pancreatic cancer. In this review, we focus on biomarkers found in the blood that can indicate early-stage pancreatic cancer, and we discuss current strategies for screening for pancreatic cancer. We recently identified a unique alteration in apolipoprotein A2 isoforms in pancreatic cancer and its precancerous lesions, and we describe its clinical usefulness as a potential biomarker for the early detection and risk stratification of pancreatic cancer.
引用
收藏
页码：1197 / 1207
页数：11
相关论文
共 63 条
  • [1] Anthropometric Measures, Body Mass Index, and Pancreatic Cancer A Pooled Analysis From the Pancreatic Cancer Cohort Consortium (PanScan)
    Arslan, Alan A.
    Helzlsouer, Kathy J.
    Kooperberg, Charles
    Shu, Xiao-Ou
    Steplowski, Emily
    Bueno-de-Mesquita, H. Bas
    Fuchs, Charles S.
    Gross, Myron D.
    Jacobs, Eric J.
    LaCroix, Andrea Z.
    Petersen, Gloria M.
    Stolzenberg-Solomon, Rachael Z.
    Zheng, Wei
    Albanes, Demetrius
    Amundadottir, Laufey
    Bamlet, William R.
    Barricarte, Aurelio
    Bingham, Sheila A.
    Boeing, Heiner
    Boutron-Ruault, Marie-Christine
    Buring, Julie E.
    Chanock, Stephen J.
    Clipp, Sandra
    Gaziano, J. Michael
    Giovannucci, Edward L.
    Hankinson, Susan E.
    Hartge, Patricia
    Hoover, Robert N.
    Hunter, David J.
    Hutchinson, Amy
    Jacobs, Kevin B.
    Kraft, Peter
    Lynch, Shannon M.
    Manjer, Jonas
    Manson, JoAnn E.
    McTiernan, Anne
    McWilliams, Robert R.
    Mendelsohn, Julie B.
    Michaud, Dominique S.
    Palli, Domenico
    Rohan, Thomas E.
    Slimani, Nadia
    Thomas, Gilles
    Tjonneland, Anne
    Tobias, Geoffrey S.
    Trichopoulos, Ditnitrios
    Virtamo, Jarmo
    Wolpin, Brian M.
    Yu, Kai
    Zeleniuch-Jacquotte, Anne
    [J]. ARCHIVES OF INTERNAL MEDICINE, 2010, 170 (09) : 791 - 802
  • [2] BLANCOVACA F, 1992, J LIPID RES, V33, P1785
  • [3] Importance of Age of Onset in Pancreatic Cancer Kindreds
    Brune, Kieran A.
    Lau, Bryan
    Paimisano, Emily
    Canto, Marcia
    Goggins, Michael G.
    Hruban, Ralph H.
    Klein, Alison P.
    [J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2010, 102 (02): : 119 - 126
  • [4] Probability of pancreatic cancer following diabetes: A population-based study
    Chari, ST
    Leibson, CL
    Rabe, KG
    Ransom, J
    De Andrade, M
    Petersen, GM
    [J]. GASTROENTEROLOGY, 2005, 129 (02) : 504 - 511
  • [5] Detecting early pancreatic cancer: Problems and prospects
    Chari, Suresh T.
    [J]. SEMINARS IN ONCOLOGY, 2007, 34 (04) : 284 - 294
  • [6] Early Detection of Sporadic Pancreatic Cancer Summative Review
    Chari, Suresh T.
    Kelly, Kimberly
    Hollingsworth, Michael A.
    Thayer, Sarah P.
    Ahlquist, David A.
    Andersen, Dana K.
    Batra, Surinder K.
    Brentnall, Teresa A.
    Canto, Marcia
    Cleeter, Deborah F.
    Firpo, Matthew A.
    Gambhir, Sanjiv Sam
    Go, Vay Liang W.
    Hines, O. Joe
    Kenner, Barbara J.
    Klimstra, David S.
    Lerch, Markus M.
    Levy, Michael J.
    Maitra, Anirban
    Mulvihill, Sean J.
    Petersen, Gloria M.
    Rhim, Andrew D.
    Simeone, Diane M.
    Srivastava, Sudhir
    Tanaka, Masao
    Vinik, Aaron I.
    Wong, David
    [J]. PANCREAS, 2015, 44 (05) : 693 - 712
  • [7] Glypican-1 as a highly sensitive and specific pancreatic cancer biomarker
    Diamandis, Eleftherios P.
    Plebani, Mario
    [J]. CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2016, 54 (01) : E1 - E2
  • [8] Cancer of the pancreas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-upaEuro
    Ducreux, M.
    Cuhna, A. Sa.
    Caramella, C.
    Hollebecque, A.
    Burtin, P.
    Goere, D.
    Seufferlein, T.
    Haustermans, K.
    Van Laethem, J. L.
    Conroy, T.
    Arnold, D.
    [J]. ANNALS OF ONCOLOGY, 2015, 26 : V56 - V68
  • [9] Identification of potential markers for the detection of pancreatic cancer through comparative serum protein expression profiling
    Ehmann, Michael
    Felix, Klaus
    Hartmann, Daniel
    Schnolzer, Martina
    Nees, Matthias
    Vorderwulbecke, Sonja
    Bogumil, Ralf
    Buchler, Markus W.
    Friess, Helmut
    [J]. PANCREAS, 2007, 34 (02) : 205 - 214
  • [10] The Early Detection Research Network's Specimen Reference Sets: Paving the Way for Rapid Evaluation of Potential Biomarkers
    Feng, Ziding
    Kagan, Jacob
    Pepe, Margaret
    Thornquist, Mark
    Rinaudo, Jo Ann
    Dahlgren, Jackie
    Krueger, Karl
    Zheng, Yingye
    Patriotis, Christos
    Huang, Ying
    Sorbara, Lynn
    Thompson, Ian
    Srivastava, Sudhir
    [J]. CLINICAL CHEMISTRY, 2013, 59 (01) : 68 - 74
1234567